Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, De Bonis M, Tribouilloy C, Evangelista A, Bogachev-Prokophiev A et al (2019) Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 140:1156–1169. https://doi.org/10.1161/circulationaha.119.041080
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A (2022) Valvular heart disease epidemiology. Med Sci (Basel) 10:32. https://doi.org/10.3390/medsci10020032
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43:561–632. https://doi.org/10.1093/eurheartj/ehab395
Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A et al (2015) Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373:2015–2024. https://doi.org/10.1056/NEJMoa1509233
Article CAS PubMed Google Scholar
Yanagisawa R, Tanaka M, Yashima F, Arai T, Jinzaki M, Shimizu H, Fukuda K, Watanabe Y, Naganuma T, Higashimori A et al (2019) Early and late leaflet thrombosis after transcatheter aortic valve replacement. Circ Cardiovasc Interv 12:e007349. https://doi.org/10.1161/circinterventions.118.007349
Article CAS PubMed Google Scholar
Bogyi M, Schernthaner RE, Loewe C, Gager GM, Dizdarevic AM, Kronberger C, Postula M, Legutko J, Velagapudi P, Hengstenberg C et al (2021) Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis. JACC Cardiovasc Interv 14:2643–2656. https://doi.org/10.1016/j.jcin.2021.09.019
Bhogal S, Waksman R, Gordon P, Ehsan A, Wilson SR, Levitt R, Parikh P, Bilfinger T, Hanna N, Buchbinder M et al (2023) Subclinical leaflet thrombosis and antithrombotic therapy post-TAVI: an LRT substudy. Int J Cardiol 371:305–311. https://doi.org/10.1016/j.ijcard.2022.10.134
Granger C, Guedeney P, Collet JP (2022) Antithrombotic therapy following transcatheter aortic valve replacement. J Clin Med 11:2190. https://doi.org/10.3390/jcm11082190
Article CAS PubMed PubMed Central Google Scholar
Tian Z, Li T, Ma S (2020) Impact of leaflet thrombosis on hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: a meta-analysis. Clin Cardiol 43:468–474. https://doi.org/10.1002/clc.23331
Article PubMed PubMed Central Google Scholar
Pieniak K, Jędrzejczyk S, Domaszk O, Grodecki K, Rymuza B, Huczek Z, Kochman J, Filipiak KJ, Gąsecka A (2020) Predictors and biomarkers of subclinical leaflet thrombosis after transcatheter aortic valve implantation. J Clin Med 9:3742. https://doi.org/10.3390/jcm9113742
Article CAS PubMed PubMed Central Google Scholar
Rosseel L, De Backer O, Søndergaard L (2018) Clinical valve thrombosis and subclinical leaflet thrombosis in transcatheter aortic heart valves: clinical manifestations, diagnosis, and treatment. Precis Clin Med 1:111–117. https://doi.org/10.1093/pcmedi/pby016
Article PubMed PubMed Central Google Scholar
Bodó I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J (2015) Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH. J Thromb Haemost. 13:1345–1350. https://doi.org/10.1111/jth.12964
Article PubMed PubMed Central Google Scholar
Stufano F, Baronciani L, Pagliari MT, Franchi F, Cozzi G, Garcia-Oya I, Bucciarelli P, Boscarino M, Peyvandi F (2015) Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination. J Thromb Haemost 13:1806–1814. https://doi.org/10.1111/jth.13062
Article CAS PubMed Google Scholar
Mahat M, Abdullah WZ, Hussin CM (2014) Conventional rapid latex agglutination in estimation of von Willebrand factor: method revisited and potential clinical applications. J Immunol Res 2014:850810. https://doi.org/10.1155/2014/850810
Article PubMed PubMed Central Google Scholar
van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622–1627. https://doi.org/10.1056/nejm199006073222302
Hillyard CJ, Blake AS, Wilson K, Rylatt DB, Miles S, Bunch R, Elms MJ, Barnes A, Bundesen PG (1987) A latex agglutination assay for D dimer: evaluation and application to the diagnosis of thrombotic disease. Clin Chem 33:1837–1840
Article CAS PubMed Google Scholar
Siller-Matula JM, Plasenzotti R, Spiel A, Quehenberger P, Jilma B (2008) Interspecies differences in coagulation profile. Thromb Haemost 100:397–404
Article CAS PubMed Google Scholar
Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 5:1315–1316. https://doi.org/10.1097/JTO.0b013e3181ec173d
Jose J, Sulimov DS, El-Mawardy M, Sato T, Allali A, Holy EW, Becker B, Landt M, Kebernik J, Schwarz B et al (2017) Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement: incidence, characteristics, and treatment outcomes. JACC Cardiovasc Interv 10:686–697. https://doi.org/10.1016/j.jcin.2017.01.045
Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, Jilaihawi H, Shiota T, Abramowitz Y, Jørgensen TH et al (2017) Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet 389:2383–2392. https://doi.org/10.1016/s0140-6736(17)30757-2
Yanagisawa R, Hayashida K, Yamada Y, Tanaka M, Yashima F, Inohara T, Arai T, Kawakami T, Maekawa Y, Tsuruta H et al (2016) Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2016.11.005
Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, Jensen KT, Blanke P, Leetmaa T, Tang M et al (2016) Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol 68:2059–2069. https://doi.org/10.1016/j.jacc.2016.08.010
D’Ascenzo F, Salizzoni S, Saglietto A, Cortese M, Latib A, Franzone A, Barbanti M, Nietlispach F, Holy EW, Burriesci G et al (2019) Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur J Cardiothorac Surg 56:488–494. https://doi.org/10.1093/ejcts/ezz099
Khan JM, Rogers T, Waksman R, Torguson R, Weissman G, Medvedofsky D, Craig PE, Zhang C, Gordon P, Ehsan A et al (2019) Hemodynamics and subclinical leaflet thrombosis in low-risk patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Imaging 12:e009608. https://doi.org/10.1161/circimaging.119.009608
Ruile P, Minners J, Breitbart P, Schoechlin S, Gick M, Pache G, Neumann FJ, Hein M (2018) Medium-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement. JACC Cardiovasc Interv 11:1164–1171. https://doi.org/10.1016/j.jcin.2018.04.006
De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, Kini AS, Veien KT, Abdel-Wahab M, Kim WK et al (2020) Reduced leaflet motion after transcatheter aortic-valve replacement. N Engl J Med 382:130–139. https://doi.org/10.1056/NEJMoa1911426
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S et al (2020) A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med 382:120–129. https://doi.org/10.1056/NEJMoa1911425
Article CAS PubMed Google Scholar
Martín M, Cuevas J, Cigarrán H, Calvo J, Morís C (2021) Transcatheter aortic valve implantation and subclinical and clinical leaflet thrombosis: multimodality imaging for diagnosis and risk stratification. Eur Cardiol 16:e35. https://doi.org/10.15420/ecr.2021.09
留言 (0)